The purpose of this interim meeting is to finalize discussion and obtain DUR Board recommendation for the Synagis criteria for the prevention of respiratory syncytial virus, specifically the coverage of infants born between 29 weeks - 1 day and 34 ...
AGENCY FOR HEALTH CARE ADMINISTRATION
The Florida Medicaid Interim Drug Utilization Review (DUR) Board Meeting announces a public meeting to which all persons are invited.
DATE AND TIME: Wednesday, May 16, 2018, 4:00 p.m. – 5:00 p.m.
PLACE: AHCA Headquarters 2727 Mahan Dr., Conference Room D, Tallahassee, FL 32308 or by phone at 1(888)670-3525, passcode: 8128510672 then #
GENERAL SUBJECT MATTER TO BE CONSIDERED: The purpose of this interim meeting is to finalize discussion and obtain DUR Board recommendation for the Synagis criteria for the prevention of respiratory syncytial virus, specifically the coverage of infants born between 29 weeks - 1 day and 34 weeks - 6 days gestational age.
A copy of the agenda may be obtained by contacting: Vern.Hamilton@ahca.myflorida.com.
Document Information
- Hearing Meeting:
- AHCA Headquarters 2727 Mahan Dr., Conference Room D, Tallahassee, FL 32308 or by phone at 1-888-670-3525, passcode 8128510672 then #
- Subject:
- The purpose of this interim meeting is to finalize discussion and obtain DUR Board recommendation for the Synagis criteria for the prevention of respiratory syncytial virus, specifically the coverage of infants born between 29 weeks - 1 day and 34 weeks - 6 days gestational age.
- Meeting:
- public meeting
- Contact:
- Vern.Hamilton@ahca.myflorida.com